MCK
McKesson Corporation NYSE Listed Nov 10, 1994$754.68
Mkt Cap $92.4B
52w Low $637.00
32.5% of range
52w High $999.00
50d MA $883.54
200d MA $813.87
P/E (TTM)
31.5x
EV/EBITDA
16.7x
P/B
—
Debt/Equity
-3.6x
ROE
-277.5%
P/FCF
16.4x
RSI (14)
—
ATR (14)
—
Beta
0.42
50d MA
$883.54
200d MA
$813.87
Avg Volume
801.9K
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
6555 State Highway 161 · Irving, TX 75039 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | AMC | 11.56 | 11.69 | +1.1% | 754.76 | -2.0% | -2.5% | — | — | — | — | — |
| Feb 4, 2026 | AMC | 9.17 | 9.34 | +1.9% | 822.00 | +4.9% | +16.5% | +15.4% | +17.1% | +13.8% | +16.0% | — |
| Nov 5, 2025 | AMC | 9.03 | 9.86 | +9.2% | 844.26 | -1.4% | +1.7% | +0.9% | +1.8% | +1.4% | -0.4% | — |
| Aug 6, 2025 | AMC | 8.14 | 8.26 | +1.5% | 703.76 | -2.9% | -5.8% | -5.0% | -4.4% | -6.4% | -5.8% | — |
| May 8, 2025 | AMC | 9.83 | 10.12 | +3.0% | 690.25 | +3.2% | +0.5% | -0.4% | -0.4% | -1.2% | +2.4% | — |
| Feb 5, 2025 | AMC | 8.60 | 8.03 | -6.6% | 606.90 | -2.8% | -1.2% | -1.8% | -0.6% | +0.6% | -2.0% | — |
| Nov 6, 2024 | AMC | 6.88 | 7.07 | +2.8% | 549.31 | +10.4% | +10.6% | +11.6% | +12.1% | +12.4% | +13.7% | — |
| Aug 7, 2024 | AMC | 7.21 | 7.88 | +9.3% | 617.51 | -7.1% | -11.3% | -12.4% | -10.8% | -10.6% | -10.5% | — |
| May 7, 2024 | AMC | 6.34 | 6.18 | -2.5% | 545.75 | +1.2% | -0.4% | +1.7% | +2.6% | +1.6% | +1.1% | — |
| Feb 7, 2024 | AMC | 7.04 | 7.74 | +9.9% | 516.98 | -2.3% | -4.4% | -3.0% | -4.4% | -2.4% | -3.1% | — |
| Nov 1, 2023 | AMC | 6.15 | 6.23 | +1.3% | 459.59 | -4.0% | -2.6% | -1.5% | +0.1% | -0.3% | +0.2% | — |
| Aug 2, 2023 | AMC | 5.87 | 7.27 | +23.9% | 413.07 | +2.3% | +5.3% | +2.1% | +2.2% | +3.5% | +3.7% | — |
| May 8, 2023 | AMC | 7.17 | 7.19 | +0.3% | 368.56 | +4.8% | +5.5% | +7.0% | +6.4% | +5.8% | +6.1% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 28 | William Blair | Initiates | Outperform | — | $828.32 | $836.33 | +1.0% | +0.8% | -0.7% | -1.6% | -1.7% | -2.5% |
| Apr 22 | UBS | Maintains | Buy → Buy | — | $842.25 | $840.77 | -0.2% | -1.5% | -0.7% | -1.7% | -1.7% | -0.9% |
| Apr 8 | Evercore ISI | Maintains | Outperform → Outperform | — | $856.62 | $859.29 | +0.3% | +1.7% | +2.0% | +1.0% | +0.9% | +0.7% |
| Apr 6 | BofA Securities | Maintains | Buy → Buy | — | $884.28 | $862.15 | -2.5% | -3.1% | -3.1% | -1.5% | -1.2% | -2.1% |
| Feb 18 | Barclays | Maintains | Overweight → Overweight | — | $946.47 | $947.43 | +0.1% | +0.1% | -1.0% | +0.1% | +0.3% | +1.2% |
| Feb 10 | JP Morgan | Maintains | Overweight → Overweight | — | $962.32 | $965.00 | +0.3% | -2.8% | -0.9% | -4.8% | -2.9% | -1.6% |
| Feb 5 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $822.00 | $862.00 | +4.9% | +16.5% | +15.4% | +17.1% | +13.8% | +16.0% |
| Feb 5 | Mizuho | Maintains | Neutral → Neutral | — | $822.00 | $862.00 | +4.9% | +16.5% | +15.4% | +17.1% | +13.8% | +16.0% |
| Feb 5 | TD Cowen | Maintains | Buy → Buy | — | $822.00 | $862.00 | +4.9% | +16.5% | +15.4% | +17.1% | +13.8% | +16.0% |
| Nov 10 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $851.99 | $842.91 | -1.1% | +0.9% | +0.5% | -1.3% | -0.7% | -1.2% |
| Nov 6 | Baird | Maintains | Outperform → Outperform | — | $844.26 | $832.35 | -1.4% | +1.7% | +0.9% | +1.8% | +1.4% | -0.4% |
| Nov 6 | UBS | Maintains | Buy → Buy | — | $844.26 | $832.35 | -1.4% | +1.7% | +0.9% | +1.8% | +1.4% | -0.4% |
| Nov 6 | Morgan Stanley | Maintains | Overweight → Overweight | — | $844.26 | $832.35 | -1.4% | +1.7% | +0.9% | +1.8% | +1.4% | -0.4% |
| Oct 27 | UBS | Maintains | Buy → Buy | — | $801.67 | $801.35 | -0.0% | +1.2% | +0.4% | +0.7% | +3.0% | +1.2% |
| Oct 14 | Jefferies | Maintains | Buy → Buy | — | $769.49 | $773.00 | +0.5% | +1.6% | +2.9% | +0.8% | +2.1% | +2.4% |
| Sep 26 | JP Morgan | Maintains | Overweight → Overweight | — | $736.52 | $743.18 | +0.9% | +3.3% | +3.4% | +4.9% | +3.9% | +3.0% |
| Sep 24 | TD Cowen | Maintains | Buy → Buy | — | $741.31 | $750.00 | +1.2% | +2.6% | -0.6% | +2.6% | +2.8% | +4.2% |
| Sep 24 | Morgan Stanley | Maintains | Overweight → Overweight | — | $741.31 | $750.00 | +1.2% | +2.6% | -0.6% | +2.6% | +2.8% | +4.2% |
| Sep 24 | Mizuho | Maintains | Neutral → Neutral | — | $741.31 | $750.00 | +1.2% | +2.6% | -0.6% | +2.6% | +2.8% | +4.2% |
| Sep 24 | Deutsche Bank | Maintains | Buy → Buy | — | $741.31 | $750.00 | +1.2% | +2.6% | -0.6% | +2.6% | +2.8% | +4.2% |
| Sep 24 | BofA Securities | Maintains | Buy → Buy | — | $741.31 | $750.00 | +1.2% | +2.6% | -0.6% | +2.6% | +2.8% | +4.2% |
| Sep 24 | Leerink Partners | Maintains | Outperform → Outperform | — | $741.31 | $750.00 | +1.2% | +2.6% | -0.6% | +2.6% | +2.8% | +4.2% |
| Sep 24 | UBS | Maintains | Buy → Buy | — | $741.31 | $750.00 | +1.2% | +2.6% | -0.6% | +2.6% | +2.8% | +4.2% |
| Sep 24 | Citigroup | Maintains | Buy → Buy | — | $741.31 | $750.00 | +1.2% | +2.6% | -0.6% | +2.6% | +2.8% | +4.2% |
| Sep 24 | Evercore ISI | Maintains | Outperform → Outperform | — | $741.31 | $750.00 | +1.2% | +2.6% | -0.6% | +2.6% | +2.8% | +4.2% |
| Sep 24 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $741.31 | $750.00 | +1.2% | +2.6% | -0.6% | +2.6% | +2.8% | +4.2% |
| Aug 13 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $659.01 | $666.50 | +1.1% | +0.6% | +2.2% | +2.1% | +1.8% | +2.7% |
| Jul 16 | Morgan Stanley | Maintains | Overweight → Overweight | — | $710.82 | $710.87 | +0.0% | +0.7% | -0.1% | -0.1% | +0.1% | -0.2% |
| Jul 9 | Evercore ISI | Maintains | Outperform → Outperform | — | $724.11 | $728.01 | +0.5% | +0.4% | -1.3% | -2.0% | -1.2% | -1.8% |
| Jun 11 | Morgan Stanley | Maintains | Overweight → Overweight | — | $704.86 | $706.51 | +0.2% | +1.8% | +3.7% | +3.3% | +2.1% | +2.8% |
| Jun 3 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $721.75 | $720.00 | -0.2% | -1.0% | -1.7% | -1.4% | -1.2% | -1.9% |
| May 9 | BofA Securities | Maintains | Buy → Buy | — | $690.25 | $712.50 | +3.2% | +0.5% | -0.4% | -0.4% | -1.2% | +2.4% |
| Apr 29 | UBS | Maintains | Buy → Buy | — | $699.73 | $701.26 | +0.2% | +1.1% | +1.9% | +1.0% | +1.2% | +1.0% |
| Apr 11 | BofA Securities | Maintains | Buy → Buy | — | $679.33 | $674.78 | -0.7% | +1.5% | +2.2% | +2.0% | +2.3% | +2.6% |
| Apr 3 | Mizuho | Maintains | Neutral → Neutral | — | $693.53 | $698.85 | +0.8% | +3.4% | -1.5% | -4.6% | -5.9% | -3.1% |
| Apr 2 | Morgan Stanley | Maintains | Overweight → Overweight | — | $673.69 | $675.76 | +0.3% | +2.9% | +6.4% | +1.4% | -1.7% | -3.1% |
| Mar 14 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $643.69 | $645.00 | +0.2% | +1.0% | +1.8% | +2.8% | +3.1% | +3.5% |
| Feb 6 | Evercore ISI | Maintains | Outperform → Outperform | — | $606.90 | $590.00 | -2.8% | -1.2% | -1.8% | -0.6% | +0.6% | -2.0% |
| Jan 10 | Citigroup | Maintains | Buy → Buy | — | $590.26 | $588.97 | -0.2% | -1.4% | -0.9% | +0.6% | -1.2% | +0.8% |
| Jan 6 | BofA Securities | Maintains | Buy → Buy | — | $577.44 | $577.00 | -0.1% | +0.5% | +1.4% | +2.2% | +0.7% | +1.3% |
| Dec 17 | Morgan Stanley | Maintains | Overweight → Overweight | — | $570.07 | $567.07 | -0.5% | -1.3% | +0.2% | +1.6% | +1.7% | +1.2% |
| Dec 13 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $579.29 | $580.32 | +0.2% | -0.5% | -1.6% | -2.9% | -1.4% | -0.0% |
| Nov 13 | Citigroup | Maintains | Buy → Buy | — | $617.66 | $618.71 | +0.2% | +1.1% | -1.2% | -1.8% | -0.3% | -0.3% |
| Nov 7 | Baird | Upgrade | Neutral → Outperform | — | $549.31 | $606.29 | +10.4% | +10.6% | +11.6% | +12.1% | +12.4% | +13.7% |
| Nov 7 | Evercore ISI | Maintains | Outperform → Outperform | — | $549.31 | $606.29 | +10.4% | +10.6% | +11.6% | +12.1% | +12.4% | +13.7% |
| Oct 7 | Leerink Partners | Maintains | Outperform → Outperform | — | $485.42 | $483.84 | -0.3% | -0.4% | +2.0% | +3.4% | +4.3% | +4.2% |
| Sep 25 | Deutsche Bank | Maintains | Buy → Buy | — | $480.49 | $483.26 | +0.6% | -0.3% | -0.3% | +1.6% | +2.9% | +3.7% |
| Sep 24 | Baird | Downgrade | Outperform → Neutral | — | $505.00 | $487.49 | -3.5% | -4.9% | -5.1% | -5.1% | -3.3% | -2.1% |
| Sep 13 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $511.17 | $509.13 | -0.4% | +1.5% | +1.7% | +0.5% | +0.1% | -0.6% |
| Sep 10 | Citigroup | Maintains | Buy → Buy | — | $509.42 | $505.00 | -0.9% | -0.7% | +0.2% | +0.3% | +1.8% | +2.0% |
No insider trades available.
8-K
McKesson Corporation -- 8-K Filing
McKesson Corporation delivered strong fourth-quarter results with 6% revenue growth to $96.3 billion and EPS increasing 35% to $13.71, demonstrating robust operational performance and profitability expansion.
May 7
8-K · 1.01
! Medium
McKesson Corporation -- 8-K 1.01: Financing / Debt Agreement
McKesson Corporation secured a $1.0 billion credit agreement, providing additional liquidity to support operations and potential strategic initiatives.
Apr 28
8-K · 1.01
! Medium
Unknown — 8-K 1.01: Financing / Debt Agreement
McKesson's new secured credit facility with leverage-based commitment fees ties borrowing costs to financial performance, incentivizing deleveraging while providing operational flexibility that investors should monitor for debt management efficiency.
Apr 6
8-K · 7.01
! Medium
McKesson Corporation -- 8-K 7.01: Regulation FD Disclosure
McKesson's Regulation FD disclosure of material information to investors signals potential guidance updates or strategic announcements that could significantly impact stock valuation and market expectations.
Mar 6
8-K · 5.02
!!! Very High
McKesson Corporation -- 8-K 5.02: Executive Change
McKesson's CFO Britt Vitalone is retiring effective March 3, 2026, creating a leadership transition that investors should monitor for potential interim management changes and strategic implications.
Mar 5
8-K
McKesson Corporation -- 8-K Filing
McKesson's third quarter revenues grew 11% to $106.2 billion while diluted earnings per share surged 34% to $9.59, demonstrating strong operational performance and margin expansion.
Feb 4
Data updated apr 26, 2026 11:30am
· Source: massive.com